Niacinamide
Showing 201 - 225 of 257
Advanced Solid Tumor Trial in Los Angeles, Rockland, Houston (Pimasertib, Temsirolimus)
Terminated
- Advanced Solid Tumor
-
Los Angeles, California
- +2 more
Oct 25, 2017
Dialysis, Cardiovascular Disease, Atherosclerosis Trial in Boston, Somerville (Extended Release Nicotinic Acid (Niaspan))
Terminated
- Dialysis
- +3 more
- Extended Release Nicotinic Acid (Niaspan)
-
Boston, Massachusetts
- +2 more
May 26, 2017
HIV, Cancer, Second Primary Trial in London (Probiotic Yogurt B: with various micronutrients, Probiotic Yogurt A: Kaiser
Completed
- HIV Infections
- Cancer, Second Primary
- Probiotic Yogurt B: with various micronutrients
- +3 more
-
London, Ontario, CanadaSt. Joseph's Hospital
Aug 25, 2017
Alzheimer's Disease Trial in Irvine (Nicotinamide, Enduramide )
Completed
- Alzheimer's Disease
- Nicotinamide
- Enduramide placebo
-
Irvine, CaliforniaUC Irvine School of Medicine
Jan 23, 2017
Aging Trial in Boulder (Niagen™, Placebo)
Completed
- Aging
- Niagen™
- Placebo
-
Boulder, ColoradoClinical Translational Research Center
Nov 29, 2016
Tumors Trial in Rockland (Pimasertib Capsule (Part A), Pimasertib Tablet (Part A), Pimasertib Capsule (Part B and trial
Completed
- Neoplasms
- Pimasertib Capsule (Part A)
- +2 more
-
Rockland, MassachusettsPlease Contact U.S. Medical Information Located in
Jul 6, 2017
End Stage Renal Disease Trial in Calgary, Edmonton (Low dose: supplemental zinc, selenium and vitamin E, Standard renal vitamin:
Completed
- End Stage Renal Disease
- Low dose: supplemental zinc, selenium and vitamin E
- +2 more
-
Calgary, Alberta, Canada
- +1 more
Dec 14, 2016
Breast Cancer, Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Philadelphia (Ixabepilone, Capecitabine, Motesanib)
Withdrawn
- Breast Cancer
- +2 more
- Ixabepilone
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Oct 19, 2016
Hyperphosphatemia Trial in Jiujiang (Nicotinic Acids, Calcium Carbonate)
Unknown status
- Hyperphosphatemia
- Nicotinic Acids
- Calcium Carbonate
-
Jiujiang, Jiangxi, ChinaJiujiang NO.1 People's Hospital
Aug 29, 2016
Diabetic Autonomic Neuropathy Trial in Ann Arbor (ORAL ANTIOXIDANT)
Completed
- Diabetic Autonomic Neuropathy
- ORAL ANTIOXIDANT
-
Ann Arbor, MichiganUniversity of Michigan
Jun 30, 2016
Advanced Solid Tumors, Hepatocellular Carcinoma Trial in Merck Serono Co., Ltd for recruiting locations in (Pimasertib)
Terminated
- Advanced Solid Tumors
- Hepatocellular Carcinoma
-
Merck Serono Co., Ltd for recruiting locations in, JapanPlease contact
Jul 19, 2017
Multiple Myeloma Trial in Baltimore (Imetelstat (7.5 mg/kg), lenalidomide standard of care, Imetelstat (9.4 mg/kg))
Completed
- Multiple Myeloma
- Imetelstat (7.5 mg/kg)
- +2 more
-
Baltimore, Maryland
- +1 more
Apr 13, 2016
Leukemia, Myeloid, Acute, Hematologic Tumors Trial in France, United States (Pimasertib)
Terminated
- Leukemia, Myeloid, Acute
- Hematologic Neoplasms
-
Chicago, Illinois
- +8 more
Jul 19, 2017
Fibroids Trial (Dydrogesterone M ( case 1 ), Dydrogesterone M ( case 2 ))
Completed
- Fibroids
- Dydrogesterone M ( case 1 )
- Dydrogesterone M ( case 2 )
- (no location specified)
Nov 30, 2015
Breast Tumors, Breast Tumors, Breast Cancer Trial (AMG 706 , Bevacizumab, AMG 706)
Terminated
- Breast Neoplasms
- +3 more
- AMG 706 placebo
- +3 more
- (no location specified)
Sep 24, 2015
Hypercholesterolemia, Familial, Heterozygous Familial Hypercholesterolemia Trial (MK-0524A)
Terminated
- Hypercholesterolemia, Familial
- Heterozygous Familial Hypercholesterolemia
- (no location specified)
Nov 2, 2015
Chronic Renal Failure, Hemodialysis Trial in France (nicotinamide, sevelamer, cinacalcet)
Terminated
- Chronic Renal Failure
- Hemodialysis
- nicotinamide
- +2 more
-
Soissons, Aisne, France
- +17 more
May 13, 2016
Pharmacokinetics of ASP015K, Food Effect, Healthy Volunteers Trial in Baltimore (ASP015K ER, ASP015K IR)
Completed
- Pharmacokinetics of ASP015K
- +2 more
- ASP015K ER
- ASP015K IR
-
Baltimore, MarylandParexel International
Aug 31, 2015
Diabetes Type 2 Trial (ER niacin/laropiprant, Comparator : (unspecified))
Completed
- Diabetes Mellitus Type 2
- ER niacin/laropiprant
- Comparator : placebo (unspecified)
- (no location specified)
Oct 9, 2015
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B
Completed
- Locally Advanced Solid Tumor
- +5 more
- MSC1936369B (pimasertib)
- SAR245409 (PI3K and mTOR inhibitor)
-
Scottsdale, Arizona
- +7 more
Jan 17, 2017